Dong MA | Cardiovascular Researches | Best Researcher Award

Posted on 04/03/202504/03/2025 by Pencis

Prof. Dong MA | Cardiovascular Researches | Best Researcher Award

Prof. Dong MA, Hebei Medical University, China

Prof. Dong Ma is a distinguished professor at Hebei Medical University, China, specializing in medical sciences and healthcare innovations. With a strong academic background, he has made significant contributions to biomedical research, clinical studies, and medical advancements. His work focuses on developing new treatments, improving patient care, and enhancing healthcare methodologies. Prof. Ma’s research is widely cited in prestigious medical journals, influencing global healthcare policies and practices. As a mentor and scholar, he continues to inspire future medical professionals while fostering international research collaborations. His dedication to medical excellence and innovation ensures a lasting impact in the field.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Dong Ma embarked on his academic journey with a strong foundation in medical sciences. He pursued his education in China, demonstrating exceptional aptitude in the field of medicine and research. His early academic years were marked by rigorous studies, participation in innovative projects, and a keen interest in medical advancements.

🏛️ PROFESSIONAL ENDEAVORS:

Prof. Ma is currently a distinguished professor at Hebei Medical University, China. Throughout his career, he has been actively involved in teaching, mentoring, and guiding students in medical sciences. His professional engagements extend beyond the classroom, contributing to the university’s research and global collaborations in medical research and healthcare advancements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCHES:

Prof. Ma’s research primarily revolves around medical sciences, healthcare innovations, and clinical applications. His work includes:

Biomedical Research: Investigating novel treatments and technologies in the medical field.
Clinical Studies: Conducting evidence-based research to improve patient care and treatment outcomes.
Medical Innovations: Developing and contributing to new methodologies and technologies in healthcare.

His dedication to research has significantly impacted both theoretical knowledge and practical medical applications, benefiting healthcare professionals and patients alike.

🌍 IMPACT AND INFLUENCE:

Prof. Ma’s contributions have made a profound impact on the medical community. His research has been cited extensively in academic journals, influencing policies and practices in the field of medicine. His work has also led to collaborations with international medical institutions, further amplifying his influence on global healthcare development.

📖 ACADEMIC CITATIONS:

Prof. Ma has been cited in numerous prestigious medical journals and research papers. His publications cover a wide range of topics, including:

Advances in medical treatments and techniques.
Healthcare policy improvements.
Breakthroughs in disease prevention and management.

His academic work serves as a valuable resource for researchers, scholars, and healthcare professionals worldwide.

🏅 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Dong Ma’s legacy is built upon his relentless pursuit of medical excellence. His future contributions are expected to:

Drive Innovation: Further enhance medical technologies and treatment approaches.
Inspire Future Scholars: Mentor upcoming medical professionals and researchers.
Expand Global Collaborations: Strengthen research ties with international institutions for broader healthcare advancements.

🔥 CONCLUSION:

Prof. Dong Ma stands as a visionary leader in medical sciences, shaping the future of healthcare through groundbreaking research, innovation, and education. His dedication to improving patient care, advancing medical treatments, and mentoring future professionals has left a lasting impact on both academia and clinical practice. With numerous contributions to medical research and extensive collaborations worldwide, he continues to drive progress in healthcare. His legacy is defined by excellence, knowledge, and a passion for medical advancements, ensuring a brighter, healthier future for generations to come.

TOP NOTABLE PUBLICATIONS

The Impact of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio on the Prognosis of Patients with Non-Viral,Non-Alcoholic Hepatocellular Carcinoma:a Retrospective Cohort Study

Authors: Xianzhe Lou, Tongguo Miao, Shiya Zhang, Dong Ma, Yuemin Nan

Journal: Chinese General Practice

Year: 2025

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma

Authors: Tongguo Miao, Shiya Zhang, Yunjing Zhang, Dong Ma, Yuemin Nan

Journal: Scientific Reports

Year: 2024

Study on the relationship between Methylation of Neuregulin (NRG) Gene and Cervical Carcinoma

Authors: Xizhao Yan, Fenglan An, Zhenzhen Ding, Dong Ma, Xiaohui Yang

Journal: Pakistan Journal of Medical Sciences

Year: 2024

α-HBDH is a superior to LDH in predicting major adverse cardiovascular events in patients with acute aortic dissection

Authors: Yunjing Zhang, Yue Sun, Yongbo Zhao, Dong Ma

Journal: Heliyon

Year: 2024

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease

Authors: Tongguo Miao, Xianzhe Lou, Shiming Dong, Dong Ma, Yuemin Nan

Journal: Journal of Hepatocellular Carcinoma

Year: 2024

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

Dr. Lingyan Chen is an Associate Researcher at Wenzhou Medical University, China, specializing in mitochondrial quality control and disease pathogenesis. She holds a Ph.D. from Wenzhou Medical University (2019-2022) and completed a postdoctoral fellowship at Guangzhou Medical University (2019-2024). Her research focuses on gene knockout models, tumor studies, and cardiovascular pharmacology. She has received multiple awards, including honors from the Circulation Journal Awards (Japan) and the Zhejiang Society of Biochemistry. With extensive experience in molecular biology techniques, Dr. Chen continues to advance biomedical research, aiming to develop novel therapeutic strategies for metabolic and cardiovascular diseases.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Lingyan Chen embarked on her academic journey at Changsha Medical University, earning a B.Sc. degree (2006-2009). She then pursued a M.Sc. at The University of South China (USC) (2015-2018), where she focused on pathogenesis and prevention of atherosclerosis, supported by prestigious research grants. She completed her Ph.D. at Wenzhou Medical University (WMU) (2019-2022), concentrating on mitochondrial quality control and its implications for related diseases.

🏥PROFESSIONAL ENDEAVORS:

🔹 Guangzhou Medical University (Postdoctoral Researcher) (2019-2024) – Advanced research in mitochondrial pathogenesis and disease modeling.
🔹 Guangzhou Medical School (Assistant Professor) (2018) – Engaged in pharmacology research on cardiovascular diseases.
🔹 Guangzhou Medical University (Research Assistant) (2018) – Coordinated multi-institutional research projects and managed key laboratory operations.
🔹 The Second People’s Hospital of Changde (Pediatric Nurse) (2009-2015) – Provided clinical care for newborns and critically ill children, mentoring trainee nurses.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Chen’s research spans multiple domains in biomedical sciences, including:
✅ Mitochondrial Quality Control & Disease Mechanisms – Investigated gene knockout/knockin mice models, heterogeneous tumors, and disease modeling for liver cancer and diabetes.
✅ Cardiovascular Pharmacology – Conducted Western Blotting, qPCR, immunofluorescence, and genetic experiments on macrophage behavior.
✅ Atherosclerosis & Hypertriglyceridemia – Studied clinical patient data, serum sample analysis, and statistical evaluations to uncover disease mechanisms.

🌍IMPACT AND INFLUENCE:

Dr. Chen has significantly influenced mitochondrial pathogenesis and cardiovascular research, contributing valuable insights into gene expression, disease prevention, and targeted treatments. Her research findings have aided in therapeutic advancements, particularly in cardiovascular disorders and metabolic diseases.

📚ACADEMIC CITES & LEGACY:

Dr. Chen’s research has been published in top-tier scientific journals, earning citations in the fields of biochemistry, molecular biology, and cardiovascular medicine. Her work serves as a foundation for future studies in mitochondrial dysfunction and therapeutic innovations.

🚀FUTURE CONTRIBUTIONS & VISION:

As an Associate Researcher at Wenzhou Medical University (2025-Present), Dr. Chen continues her groundbreaking research in mitochondrial medicine and disease pathogenesis. She aims to:
🔹 Develop novel therapeutic strategies for cardiovascular and metabolic disorders.
🔹 Expand research on genetic and molecular mechanisms underlying disease progression.
🔹 Mentor the next generation of biomedical researchers and medical professionals.

🏆AWARDS AND HONORS:

🔹 2020 – Second Prize in the 16th Graduate Academic Competition, Wenzhou Medical University
🔹 2020 – Second Prize in the “Xinzhi” Youth Forum, Zhejiang Society of Biochemistry and Molecular Biology
🔹 2018 – Second Prize for Excellent Experimental Research Paper, Circulation Journal Awards (Japan)
🔹 2018 – Outstanding Communist of the University of South China
🔹 2017 – 3rd Prize, Young Investigator Oral Presentation, 14th National Conference on Atherosclerotic Diseases & China-Canada Symposium
🔹 2017 – Excellence Award, Young Investigator Oral Presentation, Cross-Strait Cardiovascular Science Symposium
🔹 2017 – 1st Scholarship, University of South China
🔹 2016 – 2nd Scholarship, University of South China
🔹 2015 – 2nd Scholarship, University of South China

🌟CONCLUSION:

Dr. Lingyan Chen’s dedication to biomedical research, particularly in mitochondrial quality control and cardiovascular pharmacology, has significantly contributed to understanding disease mechanisms and potential treatments. Her extensive experience in molecular biology, combined with numerous accolades and publications, underscores her impact in the scientific community. As she continues her research at Wenzhou Medical University, Dr. Chen remains committed to advancing medical science, mentoring future researchers, and developing innovative therapeutic strategies. Her work holds great promise for improving treatments for metabolic and cardiovascular diseases, making her a valuable figure in the field of biomedical research.

TOP NOTABLE PUBLICATIONS

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

Authors: Chen, Lingyan; Chen, Dejian; Pan, Yiming; Zhang, Dawei; Xia, Xiaodan

Journal: Cell Death and Disease

Year: 2024

Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells

Authors: Chen, Lingyan; Chen, Dejian; Li, Jiwei; Lu, Xiaoang; Lu, Bin

Journal: Cell Death and Disease

Year: 2022

MicroRNA-377 inhibits atherosclerosis by regulating triglyceride metabolism through the DNA methyltransferase 1 in apolipoprotein E-knockout mice

Authors: Chen, Lingyan (First Author); Xia, Xiaodan; Zhao, Zhiwei; Gong, Dan; Ma, Xuefeng; Yu, Xuhui; Zhang, Qi; Wang, Shengqi; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Yin, Wende; Tang, ChaoKun

Journal: Circulation Journal

Year: 2018

Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells

Authors: Xia, Xiaodan; Yu, Xuhui; Chen, Lingyan (Co-first Author); Xie, Shuo; Feng, Yan; Yang, Rui; Zhao, Zhiwei; Li, Hui; Wang, Gang; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids

Year: 2021

Heart shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway

Authors: Zhao, Zhiwei; Zhang, Min; Chen, Lingyan (Co-first Author); Gong, Dan; Xia, Xiaodan; Yu, Xuhui; Wang, Shengqi; Ou, Xue; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta

Year: 2018

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages

Authors: Li, ChaoHui; Gong, Dan; Chen, Lingyan (Co-first Author); Zhang, Min; Xia, Xiaodan; Cheng, Hongping; Huang, Chen; Zhao, Zhiwei; Zheng, Xianliang; Tang, XueEr; Tang, ChaoKun

Journal: European Journal of Pharmacology

Year: 2017

IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells

Authors: Tang, XueEr; Li, Hui; Chen, Lingyan (Co-first Author); Xia, Xiaodan; Zhao, Zhiwei; Zheng, Xianliang; Zhao, GuoJun; Tang, ChaoKun

Journal: Cytokine

Year: 2019

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Posted on 12/02/202512/02/2025 by Pencis

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

The role of inflammation and fibrosis in cardiovascular conditions.
The impact of environmental factors, such as micro(nano)plastics, on heart disease.
Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

Journal of Hazardous Materials
Clinical and Translational Medicine
Experimental and Therapeutic Medicine
Bioengineered
American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

The development of innovative drug treatments for myocardial infarction.
The formulation of preventive measures against ischemic heart disease.
The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title: Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, … X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal: Journal of Hazardous Materials

Year: 2025

Songyun Wang | Arrhythmia | Best Researcher Award

Posted on 25/01/202525/01/2025 by Pencis

Dr. Songyun Wang | Arrhythmia | Best Researcher Award

Dr. Songyun Wang, Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China

Dr. Songyun Wang is an Associate Professor and Associate Chief Physician at the Department of Cardiology, Renmin Hospital of Wuhan University, China. He holds a B.S. in Medicine, a Ph.D. in Internal Medicine from Wuhan University, and a joint Ph.D. in Cardiovascular Disease from Mayo Medical Center, USA. With expertise in neuromodulation, neuroinflammation, and cardiovascular diseases, Dr. Wang has undertaken 24 scientific foundations and published over 60 high-impact SCI articles, including 24 as the first or corresponding author. His groundbreaking research on noninvasive neuromodulation for preventing cardiac arrhythmias highlights his commitment to advancing patient care and clinical innovation.

Author Profile

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Songyun Wang embarked on an exceptional academic journey by earning a Bachelor of Science in Medicine and a Ph.D. in Internal Medicine from the First Clinical College of Wuhan University, China. He further broadened his academic foundation through a joint Ph.D. in Cardiovascular Disease at the prestigious Mayo Medical Center in the USA. This diverse and rigorous training laid the groundwork for his expertise in cardiology and innovative research methodologies.

🩺PROFESSIONAL ENDEAVORS:

Currently serving as an Associate Professor and Associate Chief Physician at the Department of Cardiology, Renmin Hospital of Wuhan University, Dr. Wang has cemented his reputation as a key figure in cardiovascular medicine. He has been an active participant and leader in 24 scientific foundations, showcasing his dedication to advancing the field. His professional responsibilities blend clinical excellence and research innovation, reflecting his commitment to improving patient care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ARRHYTHMIA:

Dr. Wang’s research is centered on neuromodulation, neuroinflammation, and cardiovascular disease. His contributions include groundbreaking insights into the relationship between neuroinflammation and cardiovascular conditions. One of his notable achievements is the study of noninvasive low-intensity focused ultrasound neuromodulation, which has been shown to effectively prevent cardiac arrhythmias. This work has garnered significant attention and holds transformative potential for clinical applications.

🌍IMPACT AND INFLUENCE:

Dr. Wang’s prolific publication record includes over 60 high-impact SCI articles, with 24 as the first or corresponding author. His research has been widely cited and serves as a foundation for further studies in cardiovascular disease. By addressing critical gaps in knowledge and proposing innovative therapeutic strategies, Dr. Wang has become a beacon of inspiration for his peers and the next generation of researchers.

📚ACADEMIC CITATIONS:

Dr. Wang’s work has been extensively referenced in both clinical and academic circles, underscoring its importance and relevance. His studies on neuromodulation and autonomic regulation in cardiac arrhythmias are frequently cited as pioneering contributions to the field of cardiology.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang is deeply committed to the clinical translation of neuromodulation techniques, ensuring that his research directly benefits patients with arrhythmias. His vision for the future involves refining these technologies and expanding their accessibility to a broader patient population. His dedication to both innovation and patient care ensures that his legacy will resonate in the medical community for years to come.

🏆OTHER IMPORTANT HIGHLIGHTS:

Interdisciplinary Collaboration: Dr. Wang’s joint Ph.D. at Mayo Medical Center demonstrates his ability to work across borders and institutions to achieve groundbreaking results.
Clinical Relevance: His focus on translational research bridges the gap between laboratory discoveries and real-world patient care.
Inspiration to Peers: Dr. Wang’s leadership in 24 scientific foundations reflects his role as a mentor and guide to fellow researchers.

✨CONCLUSION:

Dr. Songyun Wang exemplifies the qualities of a visionary researcher, dedicated educator, and compassionate physician. His outstanding academic credentials, innovative contributions, and commitment to advancing cardiovascular medicine make him a deserving candidate for the Best Researcher Award. Through his work, Dr. Wang continues to inspire and elevate the global standard of cardiology research and practice.

TOP NOTABLE PUBLICATIONS

An Ultrasound-Activated Supramolecular Modulator Enhancing Autophagy to Prevent Ventricular Arrhythmias Post-Myocardial Infarction

Authors: Pang, Y., Li, Q., Wang, J., Liu, S., Sun, Y.

Journal: Angewandte Chemie – International Edition

Year: 2025

Noninvasive Oral Hyperspectral Imaging–Driven Digital Diagnosis of Heart Failure With Preserved Ejection Fraction: Model Development and Validation Study

Authors: Yang, X., Li, Z., Lei, L., Zhong, Y., Yu, L.

Journal: Journal of Medical Internet Research

Year: 2025

Potential Microemboli Formation Risk and Its Management During the Heated Saline–Enhanced Radiofrequency Needle-Tip Catheter Ablation

Authors: Suzuki, A., Lehmann, H.I., Konishi, H., Curley, M.G., Packer, D.L.

Journal: Heart Rhythm

Year: 2024

Wearable Ultrasound Devices: An Emerging Era for Biomedicine and Clinical Translation

Authors: Hu, H., Hu, C., Guo, W., Zhu, B., Wang, S.

Journal: Ultrasonics

Year: 2024

Subarachnoid Haemorrhage-Induced Reversible Cardiac Dysfunction: Time Course and Potential Mechanisms

Authors: Xiao, Y., Lai, X., Wang, Z., Chen, M., Zhou, S.

Journal: ESC Heart Failure

Year: 2024

Low-Intensity Focused Ultrasound Modulation of the Paraventricular Nucleus to Prevent Myocardial Infarction–Induced Ventricular Arrhythmia

Authors: Xiang, C., Cheng, Y., Yu, X., Wang, S., Jiang, H.

Journal: Heart Rhythm

Year: 2024

Efficacy, Safety, and Somatosensory Comparison of Pulsed-Field Ablation and Thermal Ablation: Outcomes From a 2-Year Follow-Up

Authors: Wang, J., Wang, X., Liu, W., Wang, S., Jiang, H.

Journal: Journal of Interventional Cardiac Electrophysiology

Year: 2024

Long-Term Transcranial Ultrasound Stimulation Regulates Neuroinflammation to Ameliorate Post–Myocardial Infarction Cardiac Arrhythmia and Remodeling

Authors: Hu, H., Wu, H., Zhu, T., Jiang, H., Wang, S.

Journal: Heart Rhythm

Year: 2024

Emerging Near-Infrared Targeting Diagnostic and Therapeutic Strategies for Ischemic Cardiovascular and Cerebrovascular Diseases

Authors: Yu, M., Wu, H., Hu, H., Jiang, H., Wang, S.

Journal: Acta Biomaterialia

Year: 2024

Mitochondria-Targeted Sonodynamic Modulation of Neuroinflammation to Protect Against Myocardial Ischemia–Reperfusion Injury

Authors: Hu, H., Li, Q., Wang, J., Sun, Y., Wang, S.

Journal: Acta Biomaterialia

Year: 2024